CCM
LEGN icon

Capstone Capital Management’s Legend Biotech LEGN Stock Holding History

Capstone Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,562
Closed -$425K – 81
2025
Q4 		$425K Buy
+19,562
New +$560K 0.41% 69

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capstone Capital Management's LEGN Position: Q1 2026 in Review

Capstone Capital Management sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 19,562 shares — an estimated $425K sold.

Capstone Capital Management first reported a position in LEGN in Q4 2025 and held it in 1 quarter. The position peaked at $425K in Q4 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Capstone Capital Management reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Capstone Capital Management sold 19,562 Legend Biotech shares in Q1 2026, an estimated $425K.
  • Capstone Capital Management first reported a position in Legend Biotech in Q4 2025 and held it in 1 quarter.
  • Capstone Capital Management's Legend Biotech position peaked at $425K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Capstone Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.